Grow longer, fuller and darker lashes with the first and only FDA-approved prescription treatment for inadequate or not enough lashes.

LATISSE® (bimatoprost ophthalmic solution) 0.03% is the first and only prescription treatment approved by the FDA for inadequate or not enough eyelashes, growing them longer, fuller and darker. It’s a once-a-day treatment that works gradually and effectively. You apply the solution topically to the base of your upper eyelashes, as instructed by your doctor. Then, results start to show in as little as 8 weeks, with full results in 16 weeks.

The science behind LATISSE®.

LATISSE® makes lash growth possible because of its active ingredient: bimatoprost. Although the precise mechanism of action is unknown, LATISSE® is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways: first, it increases the length of this phase, and second, it increases the number of hairs in this growth phase.

It’s a product whose time has come.

In 2001, Allergan developed a medicated eye drop used to lower eye pressure (known as IOP or intraocular pressure) in patients with open-angle glaucoma or ocular hypertension. As a result, patients using this medication began experiencing eyelash growth as a side effect. This led Allergan, already a pioneer in eye care, dermatological and aesthetic products, to begin studying its active ingredient. After a clinical trial, LATISSE® earned its FDA approval in December 2008. And since then, approximately 1.5 million bottles of LATISSE® have been prescribed to approximately 350,000 people.

Unretouched photos of a LATISSE® (bimatoprost ophthalmic solution) 0.03% user at week 0 and week 16.

The onset of effect with LATISSE® solution is gradual.
In the clinical trial, the majority of LATISSE® users saw significant
improvement by 2 months.1 Individual results may vary.

If discontinued, lashes will gradually return
to their previous appearance.

It is possible for a difference in eyelash length, thickness, fullness, pigmentation, number of eyelash hairs, and/or direction of eyelash growth to occur between eyes. These differences, should they occur, will usually go away if you stop using LATISSE®.

LATISSE® solution is a prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker, and darker.
Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.

Important Safety Information
If you are using prescription products for lowering eye pressure or have a history of eye pressure problems, only use LATISSE® under close doctor supervision. LATISSE® may cause eyelid skin darkening which may be reversible, and there is a potential for increased brown iris pigmentation which is likely to be permanent. There is a potential for hair growth to occur in areas where LATISSE® solution comes in repeated contact with skin surfaces. If you develop or experience any eye problems or have eye surgery, consult your doctor immediately about continued use of LATISSE®. The most common side effects after using LATISSE® solution are an itching sensation in the eyes and/or eye redness.

• Latisse Slideshow
• Clinical Trial Images – 2
• Clinical Trial Images – 3
• Featured Women Images – 1
• Featured Women Images – 2
• Featured Women Images – 3

For more information on LATISSE®, please read the prescribing information.